{"disease":{"id":"vasculitis","name":"vasculitis"},"drugs":{"marketed":[{"drug_id":"avacopan","indication_name":"Anti-Neutrophil Cytoplasmic Autoantibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis and microscopic polyangiitis)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tavneos","generic_name":"AVACOPAN","company_name":"Chemocentryx","drug_phase":"marketed","molecular_target":"C5a anaphylatoxin chemotactic receptor 1","drug_class":"Complement 5a Receptor Antagonist [EPC]","quality_score":62,"revenue":"400","mechanism":"Tavneos blocks the action of a chemical called C5a, which is involved in the body's inflammatory response."},{"drug_id":"ccx168","indication_name":"Anti-Neutrophil Cytoplasmic Autoantibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis and microscopic polyangiitis)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tavneos","generic_name":"CCX168","company_name":"Chemocentryx","drug_phase":"discontinued","molecular_target":"C5a anaphylatoxin chemotactic receptor 1","drug_class":"Complement 5a Receptor Antagonist","quality_score":null,"revenue":null,"mechanism":"Tavneos blocks the action of a chemical called C5a, which is involved in inflammation and damage to blood vessels."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06769412","title":"A Real-World Evidence Study for the Incidence of Retinal Vasculitis (RV) Among Adult Patients Receiving Aflibercept 2 mg in the United States (US)","phase":"","overall_status":"COMPLETED","enrollment_count":550000,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT04294771","title":"JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors","phase":"","overall_status":"UNKNOWN","enrollment_count":500000,"lead_sponsor_name":"Groupe Hospitalier Pitie-Salpetriere","has_results":false},{"nct_id":"NCT07105228","title":"Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study","phase":"","overall_status":"COMPLETED","enrollment_count":290000,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT05095844","title":"National Vaccine Adverse Event Reporting Survey and Etiology","phase":"","overall_status":"UNKNOWN","enrollment_count":100000,"lead_sponsor_name":"Neuroganics LLC","has_results":false},{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT07077304","title":"EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT02257866","title":"Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","has_results":false},{"nct_id":"NCT05251415","title":"Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"University Hospital, Toulouse","has_results":false},{"nct_id":"NCT05383339","title":"Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":2250,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05879419","title":"Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2005,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT00001156","title":"Assessment of Patients With Multiple Sclerosis (MS)","phase":"","overall_status":"COMPLETED","enrollment_count":1388,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT03693586","title":"Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Hospital General de Mexico","has_results":false},{"nct_id":"NCT05904301","title":"Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Santé Arménie French-Armenian Research Center","has_results":false},{"nct_id":"NCT06011512","title":"Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica.","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Salome Kristensen","has_results":false},{"nct_id":"NCT02466217","title":"Phenomics in Autoimmune and Inflammatory Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":537,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05017142","title":"Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"University of Bern","has_results":false},{"nct_id":"NCT05315141","title":"Multicenter Cohort Study of AAV in Hunan of China","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT05897684","title":"Avacostar - (PASS)","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Vifor Fresenius Medical Care Renal Pharma","has_results":false},{"nct_id":"NCT05628948","title":"Vascular Lab Resource (VLR) Biorepository","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"The Cleveland Clinic","has_results":false},{"nct_id":"NCT07188285","title":"Mass Spectrometry-based Immune Profiling in Autoimmune Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT05383573","title":"Pediatric ANCA Associated-vasculitis","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT03410290","title":"Journey of Patients With Vasculitis From First Symptom to Diagnosis","phase":"","overall_status":"COMPLETED","enrollment_count":456,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT06593041","title":"ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS","phase":"","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT02994927","title":"A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":331,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05416723","title":"Occupational and Environmental Origins of ANCA Vasculitis: Contribution of Data From the National Network for Vigilance and Prevention of Occupational Pathologies (RNV3P)","phase":"","overall_status":"UNKNOWN","enrollment_count":302,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT07354503","title":"Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT06072482","title":"A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT04664465","title":"PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT07168161","title":"BDB-001 Phase III Trial in ANCA-Associated Vasculitis","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Staidson (Beijing) Biopharmaceuticals Co., Ltd","has_results":false},{"nct_id":"NCT03762824","title":"Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT04008316","title":"Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA Vasculitis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":264,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06462768","title":"Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis","phase":"","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"CHU de Reims","has_results":false},{"nct_id":"NCT06308978","title":"A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":244,"lead_sponsor_name":"Fate Therapeutics","has_results":false},{"nct_id":"NCT06763783","title":"Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases","phase":"PHASE4","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":240,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT05716334","title":"Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator","phase":"","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT00050492","title":"Biological Markers in Retinal Vasculitis","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT07251179","title":"Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT05969522","title":"Stratified Therapy on Pediatric AAGN","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Wang Mo","has_results":false},{"nct_id":"NCT06611696","title":"Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"Chiba University","has_results":false},{"nct_id":"NCT06779799","title":"Characterization of \"Bamboo\" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases (BAMBOO)","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT06824714","title":"Prediction of Risk of Vascular Structural Damage in Patients With Large Vessel Vasculitis (LVV) Based on PET/MRA Image Evaluation System","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Nanjing Medical University","has_results":false},{"nct_id":"NCT03543527","title":"Study of Refractory and/or Relapsing TAkayasu aRTeritis","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT00331331","title":"The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease","phase":"","overall_status":"COMPLETED","enrollment_count":147,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT07010250","title":"Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":146,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04157348","title":"Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":140,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT07373262","title":"Avacopan Added to Standard-of-care Therapy in ANCA-associated Vasculitis With Severe Kidney Involvement","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":130,"lead_sponsor_name":"University Hospital, Toulouse","has_results":false},{"nct_id":"NCT05946564","title":"A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":126,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06868290","title":"Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":126,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT06698614","title":"MEMRI and Kidney Disease","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT04692363","title":"Plasmapheresis Before Rituximab in Cryoglobulinemia","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}